Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
Recruiting · NCT05370014 · Interventional (participants receive a specific treatment) · Lead sponsor: University of South Carolina
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.
Who can take part
Inclusion criteria
- COVID-19 survivor inclusion criteria
- African American
- Male and female
- Living in a Medically Underserved Area and/or a designated rural area of South Carolina
- ≥ 18 years and above
- A history of a COVID-19-associated hospitalization, ER or Urgent Care visit since March 11th, 2020
- A previous diagnosis of one or more of the following conditions: type 2 diabetes, hypertension, cardiovascular disease, chronic kidney disease, or stroke (\>3 months)
- Carepartner inclusion criteria
- Male and female
- ≥ 18 years and above
- Must live on the same property or community, preferably within a 40-mile radius of the survivor
- Primarily responsible for care provision and/or care/social support in the home (i.e., is not paid for services)
Exclusion criteria
- Survivor and Carepartner exclusion criteria • Enrolled in related clinical trials
Where it is running
1 location listed across 1 US state.
- University of South Carolina - Columbia, South Carolina, United States